| scholarly article | Q13442814 |
| P50 | author | Ola Landgren | Q66432182 |
| P2093 | author name string | Kenneth Pietz | |
| Eric A Engels | |||
| Jennifer R Kramer | |||
| Thomas P Giordano | |||
| Elizabeth Y Chiao | |||
| Louise Henderson | |||
| P2860 | cites work | Binding of hepatitis C virus to CD81 | Q22004178 |
| Recommendations for prevention and control of hepatitis C virus (HCV) infection and HCV-related chronic disease. Centers for Disease Control and Prevention | Q28286743 | ||
| The prevalence of hepatitis C virus infection in the United States, 1999 through 2002 | Q29619974 | ||
| The prevalence of hepatitis C virus infection in the United States, 1988 through 1994 | Q29620136 | ||
| The incidence of idiopathic thrombocytopenic purpura in adults increases with age. | Q33329555 | ||
| Persistence of hepatitis C virus in a human megakaryoblastic leukaemia cell line | Q33331013 | ||
| HCV-associated thrombocytopenia: clinical characteristics and platelet response after recombinant alpha2b-interferon therapy | Q33333436 | ||
| Treatment of hepatitis C related thrombocytopenia with interferon alpha | Q33340288 | ||
| Immune thrombocytopenic purpura | Q33341737 | ||
| Steroid-refractory chronic idiopathic thrombocytopenic purpura associated with hepatitis C virus infection | Q33341932 | ||
| Immune thrombocytopenic purpura in patients with chronic hepatitis C virus infection | Q33343858 | ||
| Severe autoimmune cytopenias in treatment-naive hepatitis C virus infection: clinical description of 35 cases | Q33346990 | ||
| Clinically significant newly presenting autoimmune thrombocytopenic purpura in adults: a prospective study of a population-based cohort of 245 patients | Q33349811 | ||
| Helicobacter pylori eradication in the management of patients with idiopathic thrombocytopenic purpura | Q33365690 | ||
| Hepatitis C virus-related thrombocytopenia: clinical and laboratory characteristics compared with chronic immune thrombocytopenic purpura | Q33366747 | ||
| Improvement of thrombocytopenia with disappearance of HCV RNA in patients treated by interferon-alpha therapy: possible etiology of HCV-associated immune thrombocytopenia | Q33368703 | ||
| Immune and autoimmune disorders in HCV chronic liver disease: personal experience and commentary on literature. | Q33369742 | ||
| Helicobacter pylori infection and chronic immune thrombocytopenic purpura: long-term results of bacterium eradication and association with bacterium virulence profiles | Q33375976 | ||
| Idiopathic thrombocytopenic purpura: a practice guideline developed by explicit methods for the American Society of Hematology | Q33496273 | ||
| A laboratory and thrombokinetic study of HCV-associated thrombocytopenia: a direct role of HCV in bone marrow exhaustion? | Q33496422 | ||
| Hepatitis C virus infection and autoimmune thrombocytopenic purpura | Q33496566 | ||
| High prevalence of autoimmune phenomena in hepatitis C virus antibody positive patients with lymphoproliferative and connective tissue disorders. | Q33497218 | ||
| Thrombocytopenia associated with hepatitis C viral infection | Q33497636 | ||
| Immune thrombocytopenia and alpha-interferon therapy | Q33498289 | ||
| Immunologic thrombocytopenic purpura as presenting symptom of hepatitis C infection | Q33502144 | ||
| Autoimmune hemolytic anemia in treatment-naïve chronic hepatitis C infection | Q34179674 | ||
| Interferon alpha and its contribution to autoimmunity | Q36490407 | ||
| Hepatitis C: A Multifaceted Disease: Review of Extrahepatic Manifestations | Q40483846 | ||
| Prevalence of monoclonal gammopathies in patients with hepatitis C virus infection | Q42989828 | ||
| The dynamics of hepatitis C virus binding to platelets and 2 mononuclear cell lines | Q43034754 | ||
| Hepatitis C virus-related adult chronic idiopathic thrombocytopenic purpura: experience from a single Chinese center | Q43049522 | ||
| The validity of viral hepatitis and chronic liver disease diagnoses in Veterans Affairs administrative databases | Q45332145 | ||
| Predictors of response of US veterans to treatment for the hepatitis C virus | Q45332298 | ||
| Risk of non-Hodgkin lymphoma and lymphoproliferative precursor diseases in US veterans with hepatitis C virus | Q45332364 | ||
| Elevated prevalence of hepatitis C infection in users of United States veterans medical centers | Q45333283 | ||
| Extrahepatic manifestations of hepatitis C among United States male veterans | Q45333951 | ||
| Rising prevalence of hepatitis C virus infection among patients recently diagnosed with hepatocellular carcinoma in the United States | Q45731239 | ||
| Prevalence and characteristics of Sjögren's syndrome or Sicca syndrome in chronic hepatitis C virus infection: a prospective study | Q45735097 | ||
| Pyoderma gangrenosum and exacerbation of psoriasis resulting from pegylated interferon alpha and ribavirin treatment of chronic hepatitis C. | Q50570866 | ||
| Severe autoimmune hemolytic anemia in a patient with chronic hepatitis C during treatment with peginterferon alfa-2a and ribavirin. | Q50576051 | ||
| Haemolytic anaemia to the alpha-interferon treatment: a proposed mechanism | Q72539116 | ||
| Pegylated interferon-2b-associated autoimmune thrombocytopenia in a patient with chronic hepatitis C | Q73158067 | ||
| NIH Consensus Statement on Management of Hepatitis C: 2002 | Q75442808 | ||
| Hemolytic anemia secondary to alpha-interferon treatment in a patient with chronic C hepatitis | Q77894103 | ||
| Hepatitis C infection and the increasing incidence of hepatocellular carcinoma: a population-based study | Q80947628 | ||
| P433 | issue | 4 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | autoimmune hemolytic anemia | Q28814 |
| hepatitis C | Q154869 | ||
| veteran | Q193891 | ||
| Immune thrombocytopenic purpura | Q3410984 | ||
| thrombocytopenia | Q585285 | ||
| Hepatitis C virus | Q708693 | ||
| P304 | page(s) | 357-63 | |
| P577 | publication date | 2009-02-23 | |
| P1433 | published in | JAMA Internal Medicine | Q177428 |
| P1476 | title | Risk of Immune Thrombocytopenic Purpura and Autoimmune Hemolytic Anemia Among 120 908 US Veterans With Hepatitis C Virus Infection | |
| P478 | volume | 169 |
| Q36870118 | Antiviral treatment prioritization in HCV-infected patients with extrahepatic manifestations - An Egyptian perspective |
| Q34642920 | Autoimmune disease and subsequent risk of developing alimentary tract cancers among 4.5 million US male veterans |
| Q33424591 | Autoimmune hemolytic anemia in treatment-naive chronic hepatitis C infection: a case report and review of literature |
| Q26775733 | Benign and Malignant Hematological Manifestations of Chronic Hepatitis C Virus Infection |
| Q60043897 | Early sofosbuvir-ledipasvir treatment for acute HCV infection induced severe immune thrombocytopenia - a case report |
| Q38254121 | Extrahepatic immune related manifestations in chronic hepatitis C virus infection |
| Q90602246 | Guideline on immune thrombocytopenia in adults: Associação Brasileira de Hematologia, Hemoterapia e Terapia Celular. Project guidelines: Associação Médica Brasileira - 2018 |
| Q43095876 | HBV and HCV coinfection associated with warm-type autoimmune hemolytic anemia: a case report |
| Q35068407 | HCV genotype-specific correlation with serum markers: higher predictability for genotype 4a |
| Q89850944 | Haemostatic alterations in cirrhotic patients: from primary haemostasis to fibrinolysis |
| Q37923504 | Hemolyzed specimens: a major challenge for emergency departments and clinical laboratories |
| Q33421032 | Hepatitis C virus infection among patients with chronic immune thrombocytopenic purpura in northern India |
| Q64987829 | High-throughput sequencing of IgG B-cell receptors reveals frequent usage of the rearranged IGHV4-28/IGHJ4 gene in primary immune thrombocytopenia. |
| Q33402517 | Immunological HCV-associated thrombocytopenia: short review |
| Q33394547 | Pathobiology and treatment of hepatitis virus-related thrombocytopenia |
| Q33402611 | Preoperative use of romiplostim in thrombocytopenic patients with chronic hepatitis C and liver cirrhosis |
| Q92740518 | Regression of Idiopathic Thrombocytopenic Purpura in a Patient With Eradication of Hepatitis C Virus by Direct-Acting Antivirals |
| Q33430592 | Severe Thrombotic Complication of Eltrombopag in a Cirrhotic Patient |
| Q39316000 | Successful treatment of myelodysplastic syndrome and chronic hepatitis C using combined peginterferon-α-2b and ribavirin therapy |
| Q33412844 | The effect of antiviral therapy on hepatitis C virus-related thrombocytopenia: a case report |
| Q26749277 | The pathophysiology of thrombocytopenia in chronic liver disease |
| Q33414386 | The role of eltrombopag in the management of hepatitis C virus-related thrombocytopenia |
| Q92001559 | Warm Autoimmune Hemolytic Anemia: Clinical Profile and Management |
Search more.